Track Jilin Province Huinan Changlong Bio-pharmacy Company Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Jilin Province Huinan Changlong Bio-pharmacy Company Limited 8049.HK Open Jilin Province Huinan Changlong Bio-pharmacy Company Limited in new tab

2.40 HKD
P/E
5.73
EPS
0.41
Yield
10.83%
Safety Score
17
P/B
0.68
ROE
11.99
Beta
0.29
Loading chart...
Key Metrics
P/E5.73
EPS0.41
Book Value3.47
Price to Book0.68
Debt/Equity0.02
% Insiders25.227%
Growth
Revenue Growth-0.05%
Earnings Growth0.20%
Dividend
Dividend Yield10.83%
Annual dividends0.24 HKD
Ex-Div. DateJune 22, 2026

DCF Valuation

Tweak assumptions to recompute fair value for Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
Currency: HKD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Logo Jilin Province Huinan Changlong Bio-pharmacy Company Limited Analysis (8049.HK)

China Health Care Official Website Stock

Is Jilin Province Huinan Changlong Bio-pharmacy Company Limited a good investment? Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK) is currently trading at 2.40 HKD.

In terms of valuation, the stock trades at a P/E ratio of 5.73. This relatively low multiple may signal that Jilin Province Huinan Changlong Bio-pharmacy Company Limited is undervalued compared to historical market norms.

For income investors, Jilin Province Huinan Changlong Bio-pharmacy Company Limited pays a dividend yield of 10.83%.

Investor FAQ

Does Jilin Province Huinan Changlong Bio-pharmacy Company Limited pay a dividend?

Yes, it pays an annual dividend of 0.24 HKD (10.83% yield).

What asset class is Jilin Province Huinan Changlong Bio-pharmacy Company Limited?

Jilin Province Huinan Changlong Bio-pharmacy Company Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It also engages in the manufacture and distribution of beverages and prepackaged food, as well as health products. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Exchange Ticker
HKG (Hong Kong) 8049.HK
Dividend Yield

10.83%

Annual Dividends

0.24 HKD

Next ex. div date

June 22, 2026

Historical Dividends
Year Total Dividends
2026 0.29 HKD
2025 0.27 HKD
2024 0.07 HKD
2023 0.55 HKD
2022 0.07 HKD
2021 0.06 HKD
2020 0.04 HKD
2019 0.07 HKD
2018 0.07 HKD
2012 0.01 HKD
2006 1.25 HKD

Yearly aggregated dividends

Dividends

Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Jul 10, 2026 Upcoming
Dividend
0.28718 HKD
Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Jul 18, 2025 Paid
Dividend
0.27292 HKD

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion